An international, biospecimen registry on Staphylococcus aureus in fixation or arthroplasty showed higher rates of MRSA in North American patients and poorer subjective outcomes among those with MRSA vs. methicillin-sensitive S. aureus.
Researchers from the AO trauma Clinical Priority Program (CPP) collected microbiological and immunological data, including bacterial isolates, blood, and sera, from 292 patients with long bone and joint infections.
Read more: Biospecimen Bone Infection Registry Finds Higher MRSA Rate in North America - OpenSpecimen